LysaKare 25 g/25 g solution for infusion
*Company:
Novartis Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 20 September 2023
File name
LysaKare_25-25g_REG PIL_PF23-0151_19.09.2023_clean_IPHA.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Free text change information supplied by the pharmaceutical company
Update to local representative of MAH
Updated on 20 September 2023
File name
LysaKare_25-25g_REG PIL_PF23-0151_19.09.2023_clean_IPHA.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Free text change information supplied by the pharmaceutical company
Update to local representative of MAH
Updated on 21 March 2023
File name
LysaKare_25-25g-g_REGPIL_PF23-0042__13.02.2023_clean_IPHA_1.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 21 February 2023
File name
LysaKare_25g-25g-REG SPC_PF23-0042_13.02.2023_clean_IPHA.pdf
Reasons for updating
- Change to MA holder contact details
Legal category:Product subject to restricted prescription (C)
Updated on 21 February 2023
File name
LysaKare_25-25g-g_REGPIL_PF23-0042__13.02.2023_clean_IPHA.pdf
Reasons for updating
- Change to MA holder contact details
Updated on 16 November 2021
File name
LysaKare_25g-25g-REG SPC_PF21-0170_Oct 2021_Clean_corr.pdf
Reasons for updating
- Correction of spelling/typing errors
Legal category:Product subject to restricted prescription (C)
Updated on 27 October 2021
File name
LysaKare_25-25g-g_PROPIL_PF21-0170__Oct 21_clean.pdf
Reasons for updating
- Change to MA holder contact details
Updated on 27 October 2021
File name
LysaKare_25g-25g-REG SPC_PF21-0170_Oct 2021_Clean.pdf
Reasons for updating
- Other
Legal category:Product subject to restricted prescription (C)
Updated on 19 October 2021
File name
LysaKare_25-25g-g_REG SPC_25-Jul-19_IPHA.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 19 October 2021
File name
LysaKare_25-25g-g_REG PIL_25-Jul-19_IPHA.pdf
Reasons for updating
- New PIL for new product